Abstract：【Objective】To investigate the diagnostic value of the expression of microRNA221-3p in patients with coronary heart disease. 【Methods】 From May to November 2018, 400 suspected CHD patients were selected, 290 of whom were diagnosed as CHD by coronary angiography (observation group) and 110 as non CHD patients (control group). The expression of miRNA-221-3p in serum of the two groups was detected by real-time quantitative PCR, and the diagnostic value of miRNA-221-3p in diagnosing coronary heart disease was analyzed by working characteristic curve of the subjects.【Results】There was no significant difference in gender, age, leukocyte count, serum uric acid level, creatinine and fasting blood glucose between the two groups (P>0.05); the proportion of hypertension, diabetes, smoking and the expression level of BMI, TG, TC, LDL-C and miRNA-221-3p in the observation group were significantly higher than those in the control group, while HDL-C was significantly lower than that in the control group (P<0.05). ROC curve analysis showed that the best critical point of miRNA-221-3p for the diagnosis of CHD was 3.7. When miRNA-221-3p was 3.7, the sensitivity and specificity of miRNA-221-3p for the prediction of CHD were 66.9% and 70.9% respectively, and the area under AUC curve was 0.71. 【Conclusion】miRNA-221-3p can be used as a potential biomarker for the diagnosis of coronary heart disease.
薛寒冰, 薛一南, 曹建. 冠心病患者miRNA-221-3p表达情况及临床诊断价值分析[J]. 医学临床研究, 2020, 37(11): 1664-1666.
XUE Han-bing, XUE Yi-nan, CAO Jian. Analysis of miRNA-221-3p Expression and Clinical Diagnosis Value in Patients with Coronary Heart Disease. JOURNAL OF CLINICAL RESEARCH, 2020, 37(11): 1664-1666.
[1] 张永生,刘家威,张春德.高龄冠心病患者血清Cys-C表达的临床意义及影响因素[J].医学临床研究,2019,36(8):1641-1643. [2] Lu D, Xu AD. Mini review: circular RNAs as potential clinical biomarkers for disorders in the central nervous system[J].Front Genet,2016,7:53. [3] Busch A , Eken SM , Maegdefessel L . Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease[J].Ann Transl Med,2016,4(12):236. [4] Hulsmans M , Holvoet P.MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease[J].Cardiovasc Res,2013, 100(1):7-18. [5] 冯源锡,叶新和,冯秋婷,等.不同亚型冠心病患者血清CRP和BNP水平及其与冠状动脉病变程度的相关性[J].医学临床研究,2019,36(3):580-581. [6] Tsuyoshi N, Toshio I, Takashi A . MicroRNAs and cardiovascular diseases[J].FEBS J,2011, 278(10):1619-1633. [7] D'Aquila P, Rose G, Bellizzi D, et al. Epigenetics and aging[J].Maturitas,2013,74:130-136. [8] Münzel T, Sinning C, Post F, et al. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction[J].Ann Med,2008, 40(3):180-196. [9] Caixiu L.The regulatory function of microrna-1 in arrhythmias[J].Mole Biosyst,2015, 12(2):328-333. [10] Wei T , Folkersen L , Ehrenborg E , et al. MicroRNA 486-3P as a stability marker in acute coronary syndrome[J].Bio Rep,2016, 36(3):e351. [11] Zhang X , Shao S , Geng H , et al. Expression profiles of six circulating MicroRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study[J].J Clin Endocrinol Metab,2014, 99(5):e766-e774.
2020, Vol. 37 
